GPX4 and early-onset autosomal dominant Alzheimer disease: For example, Chen et al. illustrated that boosting the levels of the ferroptosis inhibitor glutathione peroxidase 4 (GPX4) could potentially enhance the health and survival of motor neurons in vivo, offering promising therapeutic pathways for neurodegenerative disorders like Alzheimer’s disease [5,6].